BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12078049)

  • 1. [Increase of soluble Fc gamma RIIIa derived from macrophages in plasma from patients with atherosclerosis].
    Masuda M; Takahashi H
    Rinsho Byori; 2002 May; 50(5):502-5. PubMed ID: 12078049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Soluble Fc gamma RIIIa derived from macrophages].
    Masuda M; Takahashi H
    Rinsho Byori; 2003 Nov; 51(11):1102-5. PubMed ID: 14679789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Fc gamma RIIIa is present in plasma and is derived from natural killer cells.
    de Haas M; Kleijer M; Minchinton RM; Roos D; von dem Borne AE
    J Immunol; 1994 Jan; 152(2):900-7. PubMed ID: 8283059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NA-phenotype-dependent differences in neutrophil Fc gamma RIIIb expression cause differences in plasma levels of soluble Fc gamma RIII.
    Koene HR; de Haas M; Kleijer M; Roos D; von dem Borne AE
    Br J Haematol; 1996 Apr; 93(1):235-41. PubMed ID: 8611467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
    Edberg JC; Kimberly RP
    J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased soluble FcgammaRIIIa(Mphi) in plasma from patients with coronary artery diseases.
    Masuda M; Miyoshi H; Kobatake S; Nishimura N; Dong XH; Komiyama Y; Takahashi H
    Atherosclerosis; 2006 Oct; 188(2):377-83. PubMed ID: 16310791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
    de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
    J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis.
    Masuda M; Morimoto T; De Haas M; Nishimura N; Nakamoto K; Okuda K; Komiyama Y; Ogawa R; Takahashi H
    J Rheumatol; 2003 Sep; 30(9):1911-7. PubMed ID: 12966590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc gamma RIII expressed on cultured monocytes is a N-glycosylated transmembrane protein distinct from Fc gamma RIII expressed on natural killer cells.
    Edberg JC; Barinsky M; Redecha PB; Salmon JE; Kimberly RP
    J Immunol; 1990 Jun; 144(12):4729-34. PubMed ID: 2141043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils.
    Huizinga TW; de Haas M; van Oers MH; Kleijer M; Vilé H; van der Wouw PA; Moulijn A; van Weezel H; Roos D; von dem Borne AE
    Br J Haematol; 1994 Jul; 87(3):459-63. PubMed ID: 7527644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells.
    Vance BA; Huizinga TW; Wardwell K; Guyre PM
    J Immunol; 1993 Dec; 151(11):6429-39. PubMed ID: 8245476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of a gamma-chain homodimer associated with Fc gamma RIII (CD16) in cultured human monocytes.
    Masuda M; Verhoeven AJ; Roos D
    J Immunol; 1993 Dec; 151(11):6382-8. PubMed ID: 8245472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD16/Fc gamma RIII induces maturation of dendritic cells and production of several cytokines including IL-12.
    de la Salle H; Galon J; Bausinger H; Spehner D; Bohbot A; Cohen J; Cazenave JP; Fridman WH; Sautès C; Hanau D
    Adv Exp Med Biol; 1997; 417():345-52. PubMed ID: 9286384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
    Congy-Jolivet N; Bolzec A; Ternant D; Ohresser M; Watier H; Thibault G
    Cancer Res; 2008 Feb; 68(4):976-80. PubMed ID: 18281470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface expression and distribution of Fc receptor III (CD16 molecule) on human natural killer cells and polymorphonuclear neutrophils.
    Fernández-Segura E; García JM; López-Escámez JA; Campos A
    Microsc Res Tech; 1994 Jul; 28(4):277-85. PubMed ID: 7919518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
    Tamm A; Schmidt RE
    J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of NK cell and macrophage activation].
    Masuda M; Takahashi H
    Rinsho Byori; 2011 Jan; 59(1):50-4. PubMed ID: 21404581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fc gamma RIII is present in lower concentrations in the serum of patients with acute myelogenous leukemia (AML): a retrospective study.
    Fleit HB; Kobasiuk CD
    Leukemia; 1993 Aug; 7(8):1250-2. PubMed ID: 8350625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII.
    Mechetina LV; Najakshin AM; Alabyev BY; Chikaev NA; Taranin AV
    Immunogenetics; 2002 Oct; 54(7):463-8. PubMed ID: 12389094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal neutrophil phenotype and neutrophil FcRIII deficiency corrected by bone marrow transplantation.
    Minchinton RM; de Haas M; von dem Borne AE; Kleijer M; Roberts AW; Gillett EA
    Transfusion; 1995 Oct; 35(10):874-8. PubMed ID: 7570921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.